Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

PU.1 INHIBITOR DB1976 CONTROLS FIBROBLAST POLARIZATION IN SYSTEMIC SCLEROSISAND LEADS TO REGRESSION OF FIBROSIS IN DIFFERENT MODELS OF ORGAN FIBROSIS (2019) Wohlfahrt T, Rauber S, Luber M, Soare A, Weber S, Matei AE, Chen CW, et al. Conference contribution SIZE MATTERS - EXTENT OF MONOSODIUM URATE DEPOSITS BUT NOT SERUM URATE LEVEL PREDICTS COMPLETE RESOLUTION OF MONOSODIUM URATE CRYSTAL DEPOSITS IN PATIENTS WITH GOUT (2019) Bayat S, Ellmann H, Guilhon de Araujo E, Manger B, Hagen M, Kleyer A, Lell M, et al. Conference contribution HAND FUNCTION IS IMPAIRED IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND PSORIASIS COMPARED TO HEALTHY CONTROLS (2019) Liphardt AM, Liehr S, Manger E, Bieniek L, Kleyer A, Simon D, Tascilar K, et al. Conference contribution JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO (2019) Adam S, Simon N, Steffen U, Harre N, Andes F, Mueller D, Culemann S, et al. Conference contribution COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY (2019) Kampylafka E, Englbrecht M, Tascilar K, Lerchen V, Linz C, Kleyer A, Simon D, et al. Conference contribution RESOLUTION OF VASCULAR INFLAMMATION IN PATIENTS WITH GIANT CELL ARTERITIS RECEIVING GLUCOCORTICOIDS, METHOTREXATE OR TOCILIZUMAB TREATMENT-DATA FROM THE ITALIAN/GERMAN RIGA STUDY (2019) Schonau V, Roth J, Tascilar K, Rech J, Schmidt D, Kuwert T, Crescentini F, et al. Conference contribution POLYAUTOIMMUNITY AND MAJOR ORGAN INVOLVEMENT PREVALENCE IN SJOGREN'S SYNDROME: THYROID, LIVER, LUNG AND KIDNEY AS TARGETS. A SINGLE CENTER CROSS SECTIONAL STUDY (2019) Valor L, Schenker H, Hagen M, Knitza J, Rech J, Schett G Conference contribution Generation and Analysis of Human and Murine Osteoclasts (2019) Steffen U, Andes FT, Schett G Journal article Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis (2019) Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, et al. Journal article Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling (Nature Metabolism, (2019), 1, 1, (111-124), 10.1038/s42255-018-0005-8) (2019) Rauner M, Baschant U, Roetto A, Pellegrino RM, Rother S, Salbach-Hirsch J, Weidner H, et al. Journal article, Erratum